Mars 3v/3vl
Payments companies reported to CMS as associated with Mars 3v/3vl. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mars 3v/3vl, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mars 3v/3vl
These are the largest totals companies reported as associated with Mars 3v/3vl. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Themistocles Protopsaltis | New York, NY | Orthopaedic Surgery | $10,625.00 |
| Richard Hynes | Melbourne, FL | Orthopaedic Surgery | $9,059.73 |
| Conor Regan | Raleigh, NC | Orthopaedic Surgery of The Spine | $8,075.00 |
| Sravisht Iyer | New York, NY | Orthopaedic Surgery of The Spine | $3,600.00 |
| Brandon Roy-Garland | Denver, CO | Vascular Surgery | $3,500.00 |
| Martin Pham | Los Angeles, CA | Neurological Surgery | $3,186.14 |
| Daniel Denis | Kenner, LA | Neurological Surgery | $2,587.80 |
| Kunwar Khalsa | Phoenix, AZ | Orthopaedic Surgery of The Spine | $1,709.99 |
| Christopher Battista | North Charleston, SC | Orthopaedic Surgery | $1,608.51 |
| Andrew Ting | Seattle, WA | Surgery | $1,600.00 |
Prescribed Mars 3v/3vl?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.